Sign In
Buy CERS
$2.66
-0.0400 (-1.48%)
At Close: Jun 03, 2026
Cerus (NASDAQ:CERS) Stock Price Crosses Above 200-Day Moving Average – Should You Sell?
04:30am, Saturday, 28'th Feb 2026
Cerus Corporation (NASDAQ: CERS - Get Free Report)'s stock price crossed above its two hundred day moving average during trading on Friday. The stock has a two hundred day moving average of $1.81 and
Cerus Corporation to Participate in the TD Cowen 46th Annual Health Care Conference
08:30am, Friday, 20'th Feb 2026
CONCORD, Calif.--(BUSINESS WIRE)--Cerus Corporation (Nasdaq: CERS) announced today that members of the Company's management are scheduled to present at the TD Cowen 46th Annual Health Care Conference
Cerus Corporation to Release Fourth Quarter and Full-Year 2025 Financial Results on March 2, 2026
04:01pm, Tuesday, 17'th Feb 2026
CONCORD, Calif.--(BUSINESS WIRE)--Cerus Corporation (Nasdaq: CERS) announced today its fourth quarter and full-year 2025 financial results will be released on Monday, March 2, 2026, after the close of
CONCORD, Calif.--(BUSINESS WIRE)--Cerus Corporation (Nasdaq: CERS) today announced the start of the INITIATE study by the German Red Cross Blood Donation Service Baden-Württemberg – Hessen and its
Cerus Corporation Announces Preliminary Fourth Quarter and Full-Year 2025 Product Revenue and Provides Outlook
04:00pm, Sunday, 11'th Jan 2026
CONCORD, Calif.--(BUSINESS WIRE)--Cerus Corporation (Nasdaq: CERS) today announced preliminary product revenue for the fourth quarter and full-year 2025, as well as provided 2026 product revenue guida
Cerus Corporation Announces Group Purchasing Agreement with Blood Centers of America
04:15pm, Wednesday, 10'th Dec 2025
CONCORD, Calif.--(BUSINESS WIRE)--Cerus Corporation (Nasdaq: CERS) announced today that it has entered into a group purchasing agreement with Blood Centers of America (BCA), the largest blood supply c
Cerus: IFC Growth And RBC Optionality
11:07pm, Sunday, 23'rd Nov 2025
CERS develops the Intercept Blood System for platelets, plasma, and IFC. These are valuable offerings for blood transfusions. CERS Intercept provides a pathogen-reduced transfusion product suite that
Connor Clark & Lunn Investment Management Ltd. Acquires 97,592 Shares of Cerus Corporation $CERS
03:58am, Friday, 21'st Nov 2025
Connor Clark and Lunn Investment Management Ltd. boosted its holdings in Cerus Corporation (NASDAQ: CERS) by 49.2% during the second quarter, according to the company in its most recent filing with th
Cerus Corporation (CERS) Q3 2025 Earnings Call Transcript
07:06pm, Thursday, 06'th Nov 2025
Cerus Corporation ( CERS ) Q3 2025 Earnings Call November 6, 2025 4:30 PM EST Company Participants Timothy Lee William Greenman - President, CEO & Chairman Vivek Jayaraman - Chief Operating Officer Ke
Cerus Corporation Announces Record Results for Third Quarter 2025 and Raises Full Year 2025 Product Revenue Guidance
04:01pm, Thursday, 06'th Nov 2025
CONCORD, Calif.--(BUSINESS WIRE)--Cerus Corporation (Nasdaq: CERS) announced today financial results for the third quarter ended September 30, 2025, and provided a business update. “We continue to m
Cerus Corporation Announces Abstracts and Industry Workshop on IFC at the 2025 AABB Annual Meeting
08:30am, Tuesday, 21'st Oct 2025
CONCORD, Calif.--(BUSINESS WIRE)--Cerus Corporation (Nasdaq: CERS) announced today that it will host an industry workshop on the benefits of Pathogen Reduced Cryoprecipitated Fibrinogen Complex, commo
Cerus Corporation to Release Third Quarter 2025 Financial Results on November 6, 2025
04:00pm, Thursday, 16'th Oct 2025
CONCORD, Calif.--(BUSINESS WIRE)--Cerus Corporation (Nasdaq: CERS) announced today that its third quarter 2025 financial results will be released on Thursday, November 6, 2025, after the close of the
The German National Blood Advisory Committee Issues Formal Recommendation for Improving the Safety of Platelet Transfusions
09:00am, Monday, 25'th Aug 2025
CONCORD, Calif.--(BUSINESS WIRE)--Cerus Corporation (Nasdaq: CERS) announced today the publication of a new recommendation from the German National Blood Advisory Committee (Arbeitskreis Blut or AK Bl
Cerus Corporation (CERS) Q2 2025 Earnings Call Transcript
09:02pm, Tuesday, 05'th Aug 2025
Cerus Corporation (NASDAQ:CERS ) Q2 2025 Earnings Conference Call August 5, 2025 4:30 PM ET Company Participants Kevin D. Green - VP of Finance & CFO Vivek K.
Cerus Corporation Announces Second Quarter 2025 Financial Results
04:01pm, Tuesday, 05'th Aug 2025
CONCORD, Calif.--(BUSINESS WIRE)--Cerus Corporation (Nasdaq:CERS) announced financial results for the second quarter ended June 30, 2025, and provided a business update. “With our singular focus to
